BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8724896)

  • 1. Anomalous phospholipid n-6 polyunsaturated fatty acid composition in idiopathic calcium nephrolithiasis.
    Baggio B; Gambaro G; Zambon S; Marchini F; Bassi A; Bordin L; Clari G; Manzato E
    J Am Soc Nephrol; 1996 Apr; 7(4):613-20. PubMed ID: 8724896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of a link between erythrocyte band 3 phosphorylation and anion transport in patients with 'idiopathic' calcium oxalate nephrolithiasis.
    Baggio B; Bordin L; Gambaro G; Piccoli A; Marzaro G; Clari G
    Miner Electrolyte Metab; 1993; 19(1):17-20. PubMed ID: 8393959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythrocyte transmembrane flux and renal clearance of oxalate in idiopathic calcium nephrolithiasis.
    Gambaro G; Petrarulo M; Nardelotto A; Marangella M; Baggio B
    Kidney Int; 1995 Nov; 48(5):1549-52. PubMed ID: 8544412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Abnormalities in the erythrocyte membrane transport of oxalate in calcium oxalate lithogenesis].
    Baggio B; Gambaro G; Marchini F; Cicerello E; Borsatti A
    Nephrologie; 1984; 5(4):173-4. PubMed ID: 6527719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic calcium oxalate nephrolithiasis: a cellular disease.
    Gambaro G; Baggio B
    Scanning Microsc; 1992 Mar; 6(1):247-54. PubMed ID: 1626244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific modulatory effect of arachidonic acid on human red blood cell oxalate transport: clinical implications in calcium oxalate nephrolithiasis.
    Baggio B; Priante G; Brunati AM; Clari G; Bordin L
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S381-4. PubMed ID: 10541268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma phospholipid arachidonic acid content and calcium metabolism in idiopathic calcium nephrolithiasis.
    Baggio B; Budakovic A; Nassuato MA; Vezzoli G; Manzato E; Luisetto G; Zaninotto M
    Kidney Int; 2000 Sep; 58(3):1278-84. PubMed ID: 10972691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal urate transport in erythrocytes of patients with idiopathic calcium nephrolithiasis: a possible link with hyperuricosuria.
    Gambaro G; Vincenti M; Marchini F; D'Angelo A; Baggio B
    Clin Sci (Lond); 1993 Jul; 85(1):41-4. PubMed ID: 8149692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosaminoglycan content, oxalate self-exchange and protein phosphorylation in erythrocytes of patients with 'idiopathic' calcium oxalate nephrolithiasis.
    Baggio B; Marzaro G; Gambaro G; Marchini F; Williams HE; Borsatti A
    Clin Sci (Lond); 1990 Aug; 79(2):113-6. PubMed ID: 2167799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The abnormal red-cell oxalate transport is a risk factor for idiopathic calcium nephrolithiasis: a prospective study.
    Gambaro G; Marchini F; Piccoli A; Nassuato MA; Bilora F; Baggio B
    J Am Soc Nephrol; 1996 Apr; 7(4):608-12. PubMed ID: 8724895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary manipulation of delta-6-desaturase modifies phospholipid arachidonic acid levels and the urinary excretion of calcium and oxalate in the rat: insight in calcium lithogenesis.
    Gambaro G; Bordoni A; Hrelia S; Bordin L; Biagi P; Semplicini A; Clari G; Manzato E; Baggio B
    J Lab Clin Med; 2000 Jan; 135(1):89-95. PubMed ID: 10638699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Efficacy of Polyunsaturated Fatty Acids as Protectors against Calcium Oxalate Renal Stone Formation: A Review.
    Rodgers AL; Siener R
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32290564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal erythrocyte and renal frusemide-sensitive sodium transport in idiopathic calcium nephrolithiasis.
    Baggio B; Gambaro G; Marchini F; Vincenti M; Ceolotto G; Pessina AC; Semplicini A
    Clin Sci (Lond); 1994 Mar; 86(3):239-43. PubMed ID: 8156732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different effects of γ-linolenic acid (GLA) supplementation on plasma and red blood cell phospholipid fatty acid composition and calcium oxalate kidney stone risk factors in healthy subjects from two race groups with different risk profiles pose questions about the GLA-arachidonic acid-oxaluria metabolic pathway: pilot study.
    Rodgers AL; Jappie-Mahomed D; van Jaarsveld PJ
    Urolithiasis; 2018 Apr; 46(2):137-147. PubMed ID: 28623397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men.
    Vidgren HM; Agren JJ; Schwab U; Rissanen T; Hänninen O; Uusitupa MI
    Lipids; 1997 Jul; 32(7):697-705. PubMed ID: 9252957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raised transmembrane oxalate flux in red blood cells in idiopathic calcium oxalate nephrolithiasis.
    Baggio B; Gambaro G; Marchini F; Cicerello E; Borsatti A
    Lancet; 1984 Jul; 2(8393):12-3. PubMed ID: 6145933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of idiopathic calcium nephrolithiasis: update 1997.
    Baggio B; Plebani M; Gambaro G
    Crit Rev Clin Lab Sci; 1998 Apr; 35(2):153-87. PubMed ID: 9592625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal arachidonic acid content of red blood cell membranes and main lithogenic factors in stone formers.
    Messa P; Londero D; Massarino F; Paganin L; Mioni G; Zattoni F; Cannella G
    Nephrol Dial Transplant; 2000 Sep; 15(9):1388-93. PubMed ID: 10978396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction of erythrocyte abnormalities in idiopathic calcium-oxalate nephrolithiasis and reduction of urinary oxalate by oral glycosaminoglycans.
    Baggio B; Gambaro G; Marchini F; Marzaro G; Williams HE; Borsatti A
    Lancet; 1991 Aug; 338(8764):403-5. PubMed ID: 1678082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.